nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—ABCB1—adrenal gland cancer	0.986	1	CbGaD
Norethindrone—Danazol—GNRHR—adrenal gland cancer	0.00837	0.766	CrCbGaD
Norethindrone—Drospirenone—PTGS2—adrenal gland cancer	0.000975	0.0892	CrCbGaD
Norethindrone—SHBG—Nongenotropic Androgen signaling—GNRH1—adrenal gland cancer	0.000576	0.19	CbGpPWpGaD
Norethindrone—Ethinyl Estradiol—ABCB1—adrenal gland cancer	0.00057	0.0522	CrCbGaD
Norethindrone—Hydrocortisone—ABCB1—adrenal gland cancer	0.000392	0.0359	CrCbGaD
Norethindrone—PGR—Ovarian Infertility Genes—NR5A1—adrenal gland cancer	0.000333	0.11	CbGpPWpGaD
Norethindrone—Progesterone—ABCB1—adrenal gland cancer	0.00032	0.0292	CrCbGaD
Norethindrone—SHBG—Nongenotropic Androgen signaling—CDC42—adrenal gland cancer	0.000313	0.103	CbGpPWpGaD
Norethindrone—Testosterone—ABCB1—adrenal gland cancer	0.000302	0.0276	CrCbGaD
Norethindrone—PGR—Nuclear Receptors—NR5A1—adrenal gland cancer	0.00029	0.096	CbGpPWpGaD
Norethindrone—PGR—Nuclear Receptor transcription pathway—NR5A1—adrenal gland cancer	0.000229	0.0758	CbGpPWpGaD
Norethindrone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	6.73e-05	0.0223	CbGpPWpGaD
Norethindrone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—adrenal gland cancer	5.03e-05	0.0166	CbGpPWpGaD
Norethindrone—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	4.78e-05	0.0158	CbGpPWpGaD
Norethindrone—PGR—Generic Transcription Pathway—NR5A1—adrenal gland cancer	3.96e-05	0.0131	CbGpPWpGaD
Norethindrone—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	3.69e-05	0.0122	CbGpPWpGaD
Norethindrone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	3.68e-05	0.0122	CbGpPWpGaD
Norethindrone—ALB—Lipid and lipoprotein metabolism—PRKACA—adrenal gland cancer	3.62e-05	0.012	CbGpPWpGaD
Norethindrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	3.22e-05	0.0107	CbGpPWpGaD
Norethindrone—ALB—Platelet degranulation—SPARC—adrenal gland cancer	2.95e-05	0.00974	CbGpPWpGaD
Norethindrone—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—adrenal gland cancer	2.81e-05	0.00928	CbGpPWpGaD
Norethindrone—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	2.74e-05	0.00907	CbGpPWpGaD
Norethindrone—PGR—Signaling by ERBB4—BAD—adrenal gland cancer	2.48e-05	0.00822	CbGpPWpGaD
Norethindrone—PGR—Generic Transcription Pathway—MED12—adrenal gland cancer	2.38e-05	0.00787	CbGpPWpGaD
Norethindrone—PGR—Generic Transcription Pathway—MEN1—adrenal gland cancer	2.28e-05	0.00752	CbGpPWpGaD
Norethindrone—CYP3A7—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	2.22e-05	0.00735	CbGpPWpGaD
Norethindrone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	2.22e-05	0.00734	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	2.15e-05	0.0071	CbGpPWpGaD
Norethindrone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	2.12e-05	0.007	CbGpPWpGaD
Norethindrone—ALB—Platelet degranulation—IGF2—adrenal gland cancer	2.03e-05	0.00672	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	2e-05	0.0066	CbGpPWpGaD
Norethindrone—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	1.98e-05	0.00656	CbGpPWpGaD
Norethindrone—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	1.94e-05	0.0064	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—NR5A1—adrenal gland cancer	1.91e-05	0.00631	CbGpPWpGaD
Norethindrone—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	1.73e-05	0.00572	CbGpPWpGaD
Norethindrone—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	1.61e-05	0.00531	CbGpPWpGaD
Norethindrone—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	1.53e-05	0.00507	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—GNRHR—adrenal gland cancer	1.42e-05	0.00469	CbGpPWpGaD
Norethindrone—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	1.41e-05	0.00468	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SH3KBP1—adrenal gland cancer	1.32e-05	0.00436	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	1.31e-05	0.00432	CbGpPWpGaD
Norethindrone—PGR—Signaling by ERBB4—EGFR—adrenal gland cancer	1.3e-05	0.00428	CbGpPWpGaD
Norethindrone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	1.24e-05	0.00411	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—ZNRF3—adrenal gland cancer	1.24e-05	0.0041	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	1.23e-05	0.00408	CbGpPWpGaD
Norethindrone—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	1.18e-05	0.00391	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—MED12—adrenal gland cancer	1.15e-05	0.00379	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—MEN1—adrenal gland cancer	1.1e-05	0.00362	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—SDHB—adrenal gland cancer	1.06e-05	0.00349	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	1e-05	0.00332	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	9.35e-06	0.00309	CbGpPWpGaD
Norethindrone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	9.22e-06	0.00305	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	9.02e-06	0.00298	CbGpPWpGaD
Norethindrone—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	8.54e-06	0.00282	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—GNRH1—adrenal gland cancer	8.5e-06	0.00281	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SPRY2—adrenal gland cancer	7.77e-06	0.00257	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—SDHB—adrenal gland cancer	7.64e-06	0.00252	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TSHR—adrenal gland cancer	7.58e-06	0.0025	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—TP53—adrenal gland cancer	7.51e-06	0.00248	CbGpPWpGaD
Norethindrone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	7.47e-06	0.00247	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MEN1—adrenal gland cancer	7.12e-06	0.00236	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	7.09e-06	0.00235	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—RRM1—adrenal gland cancer	6.81e-06	0.00225	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—SDHD—adrenal gland cancer	6.81e-06	0.00225	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—SPARC—adrenal gland cancer	6.73e-06	0.00223	CbGpPWpGaD
Norethindrone—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	6.6e-06	0.00218	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SDHB—adrenal gland cancer	6.58e-06	0.00217	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	6.43e-06	0.00213	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	6.37e-06	0.00211	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SDHB—adrenal gland cancer	5.9e-06	0.00195	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SDHB—adrenal gland cancer	5.76e-06	0.0019	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PRKACA—adrenal gland cancer	5.68e-06	0.00188	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PRKACA—adrenal gland cancer	5.44e-06	0.0018	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.17e-06	0.00171	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MED12—adrenal gland cancer	5.07e-06	0.00168	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	4.92e-06	0.00163	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—SDHD—adrenal gland cancer	4.92e-06	0.00163	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—RRM1—adrenal gland cancer	4.92e-06	0.00163	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—CDC42—adrenal gland cancer	4.82e-06	0.00159	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	4.73e-06	0.00156	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IGF2—adrenal gland cancer	4.65e-06	0.00154	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.65e-06	0.00154	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDC42—adrenal gland cancer	4.61e-06	0.00152	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—GNAS—adrenal gland cancer	4.61e-06	0.00152	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IGF2—adrenal gland cancer	4.45e-06	0.00147	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—GNAS—adrenal gland cancer	4.41e-06	0.00146	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	4.31e-06	0.00143	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IGF1R—adrenal gland cancer	4.3e-06	0.00142	CbGpPWpGaD
Norethindrone—ALB—Metabolism—RRM1—adrenal gland cancer	4.24e-06	0.0014	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SDHD—adrenal gland cancer	4.24e-06	0.0014	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	4.23e-06	0.0014	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.99e-06	0.00132	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	3.97e-06	0.00131	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	3.91e-06	0.00129	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—RRM1—adrenal gland cancer	3.8e-06	0.00126	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SDHD—adrenal gland cancer	3.8e-06	0.00126	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—RRM1—adrenal gland cancer	3.71e-06	0.00123	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SDHD—adrenal gland cancer	3.71e-06	0.00123	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	3.7e-06	0.00122	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TERT—adrenal gland cancer	3.7e-06	0.00122	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MED12—adrenal gland cancer	3.67e-06	0.00121	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SDHB—adrenal gland cancer	3.55e-06	0.00117	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.49e-06	0.00116	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.35e-06	0.00111	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—BAD—adrenal gland cancer	3.22e-06	0.00106	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MED12—adrenal gland cancer	3.16e-06	0.00104	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GNAS—adrenal gland cancer	3e-06	0.000992	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—POMC—adrenal gland cancer	2.97e-06	0.000981	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	2.94e-06	0.000973	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—BRAF—adrenal gland cancer	2.93e-06	0.000969	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MED12—adrenal gland cancer	2.84e-06	0.000938	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.82e-06	0.000934	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.81e-06	0.00093	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MED12—adrenal gland cancer	2.77e-06	0.000915	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	2.68e-06	0.000885	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.54e-06	0.000838	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PRKACA—adrenal gland cancer	2.3e-06	0.000762	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SDHD—adrenal gland cancer	2.29e-06	0.000756	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—RRM1—adrenal gland cancer	2.29e-06	0.000756	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.25e-06	0.000745	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GNAS—adrenal gland cancer	2.17e-06	0.000717	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	2.13e-06	0.000704	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CTNNB1—adrenal gland cancer	2.12e-06	0.0007	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	2.07e-06	0.000684	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.02e-06	0.000669	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—POMC—adrenal gland cancer	2.02e-06	0.000668	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.02e-06	0.000668	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GNAS—adrenal gland cancer	1.87e-06	0.000618	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ABCB1—adrenal gland cancer	1.83e-06	0.000606	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.71e-06	0.000564	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—EGFR—adrenal gland cancer	1.68e-06	0.000555	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GNAS—adrenal gland cancer	1.68e-06	0.000554	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	1.65e-06	0.000544	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.64e-06	0.000541	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	1.61e-06	0.000533	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TP53—adrenal gland cancer	1.47e-06	0.000487	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—POMC—adrenal gland cancer	1.46e-06	0.000483	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TP53—adrenal gland cancer	1.41e-06	0.000466	CbGpPWpGaD
Norethindrone—ALB—Metabolism—POMC—adrenal gland cancer	1.26e-06	0.000416	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.24e-06	0.000411	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	1.16e-06	0.000385	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.13e-06	0.000373	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—POMC—adrenal gland cancer	1.1e-06	0.000364	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.01e-06	0.000333	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS2—adrenal gland cancer	1e-06	0.000332	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	9.89e-07	0.000327	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	9.01e-07	0.000298	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS2—adrenal gland cancer	8.79e-07	0.000291	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—POMC—adrenal gland cancer	6.79e-07	0.000224	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	5.42e-07	0.000179	CbGpPWpGaD
